CONMED (CNMD) Downgraded by Zacks Investment Research to Sell

CONMED} stock has undergone multiple analysts rating changes in the recent past.  CONMED Downgraded by Zacks Investment Research on 10-11-21. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More CONMED (CNMD) Downgraded by Zacks Investment Research to Sell